(Press-News.org) Miami (May 1, 2025) – Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people with chronic obstructive pulmonary disease (COPD) who also require supplemental oxygen, according to a new report. The report is published in the March 2025 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open-access journal.
COPD is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution. The disease affects more than 30 million Americans and is the fourth leading cause of death worldwide.
Pulmonary rehabilitation is an exercise and educational program supervised by a health care professional, which helps people with chronic breathing difficulties. These programs teach people how to manage their symptoms and improve their quality of life. Pulmonary rehabilitation programs are traditionally held in person; however, virtual or online programs are also available.
In this new report, the authors examined the feasibility, safety and effectiveness of a virtual pulmonary rehabilitation program for people with COPD who did and did not require supplemental oxygen. The report compared the attendance rates, safety and improvements in symptoms, mood and exercise capacity for the two groups.
“Virtual pulmonary rehabilitation allows for increased access to these programs, which benefit people with COPD, regardless of their supplemental oxygen use. In our study, 99% of participants participated safely without any adverse effect, and participants in both groups had improvements in clinical outcomes,” said Russell Buhr, M.D., Ph.D., a pulmonologist at the University of California, Los Angeles, and co-senior author of the report. “Our findings demonstrate the need to increase use of virtual pulmonary rehabilitation programs to help improve the quality of life for people with COPD. By evaluating each patient’s situation and incorporating virtually accessible programs, we can offer more individualized care for patients.”
To access current and past issues of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, visit journal.copdfoundation.org.
###
About the COPD Foundation
The COPD Foundation is a nonprofit organization whose mission is to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop COPD, bronchiectasis, and NTM lung disease. The Foundation does this through scientific research, education, advocacy, and awareness to prevent disease, slow progression, and find a cure. For more information, visit copdfoundation.org, or follow us on Twitter and LinkedIn.
END
WASHINGTON – Many people around the world believe in karma – that idea that divine justice will punish people who do bad deeds and reward those who good. But that belief plays out differently for oneself versus others, according to research published by the American Psychological Association.
People are more likely to believe that they’ve earned good things in their own life through karmic merit, while bad things that happen to other people are due to karmic punishment, according ...
Washington, D.C. – May 1, 2025 – Analyses from the (Ergonomics in the Cardiac Catheterization Laboratory (ERGO-CATH) study show the traditional approach using a lead apron causes 43% of interventional cardiologists to experience discomfort, building on existing consensus of the significant occupational health risks that exist in the catheterization (cath) lab. The data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions in Washington, D.C.
The cath lab is a designated ...
Washington, D.C. – MAY 1, 2025 – Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that single antiplatelet therapy (SAPT) after transcatheter aortic valve replacement (TAVR) is associated with a significantly lower incidence of six-month mortality and major bleeding risk compared to dual antiplatelet therapy (DAPT). The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.
The current standard of care following TAVR is SAPT, which involves the use of only one ...
Press Contacts:
Gavin Stern
gstern@scai.org, 202-644-8561
Annika Parrish
aparrish@brgcommunications.com, 703-793-8356
WOMEN AND BLACK PATIENTS FACE HIGHER RISKS AND UNEQUAL ACCESS IN ADVANCED CARDIOVASCULAR PROCEDURES
Women Experience Higher Risk of Serious Cardiovascular Events After Transcatheter Aortic Valve Implantation and Left Atrial Appendage Occlusion Device Placement
Black Patients with Chronic Limb-Threatening Ischemia Almost 50% More Likely to Require Major Amputation Yet 10% ...
Fukuoka, Japan—The duplication and division of cells is critical to keeping all multicellular organisms alive. But the opposite process is equally important: cell death. Controlled death of cells, or programmed cell death, is also necessary for the proper development and function of the body. It has also been a focus of researchers developing treatments for cancer by finding ways to activate the cell death of cancer cells themselves.
Ferroptosis is a recently discovered form of programmed cell death and has been a promising target for the ...
Washington, D.C. – MAY 1, 2025 – In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and fewer cardiac arrests at one year. The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.
Coronary artery disease (CAD) is the most common type of heart disease and a leading cause of death worldwide. CTO PCI is a minimally invasive procedure to treat CAD by reopening blocked arteries with a catheter and stent. CTO PCI is a ...
Washington, D.C. – MAY 1, 2025 – The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs) demonstrated good safety outcomes, such as mortality and adverse event rates at 30 days, compared to outpatient hospital departments, but were less likely to use certain technologies. The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.
Ambulatory surgery centers (ASCs) are non-hospital facilities that provide same-day surgical or procedural ...
Background and Aims
Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide. This study aimed to explore the role of TM6SF2 in high-fat diet (HFD)-induced MASLD through the gut-liver axis.
Methods
The TM6SF2 gut-specific knockout (TM6SF2 GKO) mouse was constructed using CRISPR/Cas9 technology. TM6SF2 GKO and wild-type (CON) mice were fed either a HFD or a control diet for 16 weeks to induce MASLD. Blood, liver, and intestinal lipid content, as well as gut microbiota and serum metabolites, were then analyzed.
Results
TM6SF2 GKO ...
Washington, D.C. – MAY 1, 2025 – In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes, including care escalation, CS deterioration, or in-hospital mortality. The data were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.
CS is a life-threatening condition in which the heart cannot pump enough blood to meet the body’s needs. As a result, your blood pressure may suddenly drop to dangerous levels, and if CS isn’t diagnosed and treated ...
FORT LAUDERDALE, Fla. — A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid, the Nova Southeastern University (NSU) and the Schmidt Initiative for Long Covid (SILC) announced today.
With funding from SILC, NSU researchers led by Dr. Nancy Klimas are enrolling 100 patients in the multi-year study with the goal of improving their Long Covid symptoms and restoring them to full health.
“Like ...
